Anti-angiogenic therapy has been shown to normalize abnormal tumor vasculature, thereby enhancing T-cell infiltration, reducing suppressive immune cell recruitment, and downregulating hypoxia-mediated inhibitory signals such as PD-L1. Here, CD274 is linked to neoplasm.